An Open-Label Adaptive Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Efficacy of Multiple Doses of Radiprodil in Subjects With Drug-Resistant Infantile Spasms

Trial Profile

An Open-Label Adaptive Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Efficacy of Multiple Doses of Radiprodil in Subjects With Drug-Resistant Infantile Spasms

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Radiprodil (Primary)
  • Indications Infantile spasms
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 27 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 1 Aug 2017.
    • 02 Jun 2017 Planned initiation date changed from 1 May 2017 to 1 Jul 2017.
    • 27 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top